A children's book about the 'nano-pill'. A spectacular 3D
glimpse into this very phenomenon during his 'Dies Natalis'
Lecture. Albert van den Berg has other ideas for the newly awarded
Spinoza Premium besides high-powered research. He wants to
communicate his work to the broadest possible audience.
Ronald Plasterk, Dutch Minister of Education, who presented the
Spinoza Premiums on 25 November, also received a copy of 'A pill
with a lab inside' ('Een pil met een lab erin'), which explains the
research of Albert van den Berg to eight-year-olds. The guests at
the Spinoza ceremony were treated to a sneak preview before the
book goes on sale in January. Van den Berg: "I said from the
beginning that I would spend some of the money on explaining what I
do. What better place to start than the earliest age group?" The
book, written by Martine Letterie, tells the story of Nanne and
Floor, who get to take a peek inside the Nanolab of MESA+ on the UT
campus. Then, in the hospital, they meet oncologist Bob Pinedo who
is busy developing a nano-pill with Albert van den Berg so that
colonic cancer can be detected at an early stage. A serious story
packed with thrilling adventures.
No more painful examinations
"Colonic cancer is one of the most common cancers in people over
the age of 50", says Van den Berg. "The Dutch Health Board has
already advised endoscopic or colonoscopic screening for people in
this age group. But this is a painful and uncomfortable experience.
What is more, it presents a logistical nightmare. And nothing is
found in 95% of cases. What we need is a simple first-line test.
The only alternative at present is a faeces test, but eventually, a
nano-pill will provide a much more patient-friendly alternative."
The nano-pill will be a lab-on-a-chip with nano threads which
detect tiny cancer-specific DNA fragments long before the tumour
develops. That way, colonic cancer - or a predisposition for
colonic cancer - can be identified far sooner. You simply swallow
the pill, which is later expelled naturally. "Picture a situation
in which the results are passed on to the doctor via a mobile
phone. Technically this is already possible", says Van den Berg,
who previously received a grant from the European Research Council
for his eLab4Life project.
Quality of life
The nano-pill is not yet ready, but Albert van den Berg's
research group is working on another system that is almost
market-ripe. This system monitors lithium levels in the blood of
patients with bi-polar disorders. A major healthcare insurer in The
Netherlands found this important for the quality of life: instead
of a lab test with the inevitable waiting times and uncertainty, a
simple jab will deliver an almost immediate result. MediMate, the
spin-off that is developing a compact measuring device on the basis
of a chip, is currently working hard on the market launch. Van den
Berg: "Chip technology will dramatically lower healthcare costs and
improve the quality of care at the same time. Soon we will be able
to apply the same technology to monitor potassium in kidney
patients. We are already monitoring calcium in cattle to prevent
milk disorders." Blue4Green, the spin-off that developed this
system, recently won the Young Technology Award.
Migraine
"One of the best offshoots of this year's Spinoza Premiums is
that we have joined forces in a new project to research the causes
of migraine. Michel Ferrari is a top international specialist in
this field and Marten Scheffer knows all about the complex
transitional situations that play a role in migraine. We can
develop chips to measure glutamate, one of the neurotransmitters.
This is the first time that prize-winners have come together in
this way. In fact, the project was already in the pipeline when the
announcements were made in June."
During the Dies Natalis (Foundation Day) Lecture on 27
November 2009 Albert van den Berg introduced the public to the
'chips for life' and the nano-pill. Wearing 3D goggles everyone
could take a look inside the phenomenon known as
lab-on-a-chip.
For more information you can contact one of the following persons:
Science writer UT
Wiebe van der Veen
+ 31 53 489 4244
Send E-mail